Stock Alert: Genetron Holdings Shares Surge 24%
Shares of Genetron Holdings Ltd. (GTH) are rising over 24%, after the company announced an exclusive strategic partnership agreement with Chia Tai Tianqing Pharmaceutical Group Co. Ltd., a subsidiary of Sino Biopharmaceutical Ltd., for HCCscreen, Genetron Health’s blood-based early screening test for hepatocellular carcinoma or HCC in China.
As per the deal, the companies would work together exclusively to co-market and co-promote HCCscreen in the hospital market, covering designated territories in China.
The stock has been trading in the range of $9.03 – $17.71 for the past one year, and is currently trading at $17.10, up $3.39 or 24.72%, with trading volume of 483K versus an average volume of 316K shares.
Source: Read Full Article